Aigen Investment Management, LP Corcept Therapeutics Inc Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $392,180 - $460,043	18,292 New	18,292 $406,000
Q3 2022 Nov 09, 2022	BUY	$24.7 - $29.12 $288,421 - $340,034	11,677 New	11,677 $299,000
Q1 2022 May 05, 2022	SELL	$16.53 - $25.21 $167,415 - $255,326	-10,128 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$17.1 - $23.34 $173,188 - $236,387	10,128 New	10,128 $201,000
Q4 2020 Feb 12, 2021	SELL	$16.78 - $27.3 $1.4 Million - $2.28 Million	-83,599 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$12.46 - $19.98 $712,961 - $1.14 Million	-57,220 Reduced 40.63%	83,599 $1.46 Million
Q2 2020 Aug 10, 2020	BUY	$11.0 - $18.26 $1.36 Million - $2.26 Million	123,703 Added 722.73%	140,819 $2.37 Million
Q1 2020 May 08, 2020	BUY	$10.11 - $14.04 $173,042 - $240,308	17,116 New	17,116 $204,000

355

86.2M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $7.17B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.